EYPT ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/5/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-1.09
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)507.00K
EyePoint Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ EyePoint Pharmaceuticals Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ EyePoint Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ EyePoint Pharmaceuticals Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ EyePoint Pharmaceuticals Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
EYPT ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
EYPT FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-3.17-36.22%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)31.37M-27.50%
EyePoint Pharmaceuticals Inc(EYPT) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -1.09/-0.95 | 507.00K/406.86K | -14.73% | 24.61% |
| 5/6/2026 | 03/2026 | -0.99/-0.81 | 696.00K/352.83K | -22.11% | 97.26% |
| 3/4/2026 | 12/2025 | -0.81/-0.75 | 620.00K/1.01M | -8.75% | -38.61% |
| 11/5/2025 | 09/2025 | -0.85/-0.78 | 966.00K/3.33M | -8.47% | -70.99% |
| 8/6/2025 | 06/2025 | -0.85/-0.80 | 5.33M/6.63M | -6.62% | -19.52% |
| 5/7/2025 | 03/2025 | -0.65/-0.66 | 24.45M/7.98M | 1.17% | 206.54% |
| 3/5/2025 | 12/2024 | -0.64/-0.50 | 11.59M/11.09M | -27.81% | 4.47% |
| 11/7/2024 | 09/2024 | -0.54/-0.56 | 10.52M/10.07M | 3.13% | 4.46% |